ROBIN HOWARD W (President & CEO) sold 0.8% of their position (418.00 shares) of NEKTAR THERAPEUTICS on the open market
Open‑market sale worth $30.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/20/2026ACC: 0001193125-26-359586
DirectorOfficer· President & CEO
Since Aug 2018
-418.00
Net shares
Net seller
$30.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
418.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−418.00
Price / share
$71.98
Trade value
$30.09K
% of position
0.8%
8/18/2026
55.05K→54.63K
Total
Net shares
−418.00
Net value
-$30.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/18/2026 | S · Sale | −418.00 | $71.98 | $30.09K | 0.8% | 55.05K | 54.63K |
| Total | −418.00 | -$30.09K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned28.00
Total
28.00 indirect28.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 28.00 | Indirect |
| Total | 28.00 | 28.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported